The China Securities Regulatory Commission has said it will resume IPO approvals once it has improved listing procedures to ensure companies are properly vetted, as if the year-long halt is simply a mild technical inconvenience. Most observers think the real reason for the freeze is that regulators fear a flood of new share issues would swamp an already shaky market and so lead to a collapse in stock prices.
Whatever the exact concerns, it is a clear case of the cure being worse than the disease. The suspension of IPOs has harmed China's companies and financial system in multiple ways, and the longer the suspension continues the worse the damage will become.
The biggest victims are those companies stuck in the queue. Many are large entities with established reputations, proven business models and a need for capital to fund their expansion. They range from state-owned monoliths like China Postal Express and Logistics, which runs the country's largest delivery service with 100,000 employees, to China Grand Auto, a major car dealer backed by US private equity firm TPG.
(Read more: China HSBC flash PMI hits a seven-month high)
Blocked from listing in China, some are looking to other exchanges. China Grand Auto, for example, is said to be exploring an IPO in Hong Kong. But these work-arounds are far from ideal. For a company whose main operations and ambitions are domestic, it means raising money in a foreign market and then jumping through the hoops of China's strict capital controls to channel the money where it is actually needed.
Smaller companies caught in China's IPO black hole have it even worse. These include businesses such as Yongxiang Food Processing Machinery and Neatus Traditional Chinese Medicine, which had both been vying to list on ChiNext, an exchange dedicated to high-tech start-ups.
The logic for launching ChiNext in 2009 was that high-growth companies in China were ill-served by the country's capital markets, struggling even to get loans from banks. ChiNext has had its problems – some of its early companies have been exposed as frauds and the overall board now trades at a bubbly 55 times price-to-earnings ratio.
(Read more: China set for best quarterly growth this year)
But it has provided small companies with a significant new venue for raising funds – until IPOs were halted, that is. China has repeatedly said it wants to promote innovative industries from biotech to renewable energy and information technology to high-end manufacturing. Preventing all start-ups from tapping the stock market is certainly a curious way of going about it.
China's financial system is also suffering. Private equity firms that had eyed listings as exits for their investments are being saddled with portfolio companies for longer than planned, making it harder to reinvest their capital in new opportunities. Brokerages are smarting, too. Their revenue from underwriting fell 26.4 per cent year-on-year in the first half.